Calciscon AG logo

Calciscon AG

Calcification Propensity Diagnostics can predict effective drugs to slow down vascular calcification and prevent cardiovascular disease.

6 employees · est. 2013 · Switzerland

VS
Diazyme Laboratories, Inc. logo

Diazyme Laboratories, Inc.

Innovations in Clinical Diagnostics

90 employees · est. 2000 · Poway, United States

Diazyme Laboratories, Inc. is the older company (2013 vs 2000); Diazyme Laboratories, Inc. is the larger of the two.

Side-by-Side Comparison

Calciscon AG Diazyme Laboratories, Inc.
Founded
2013 2000 older
Headquarters
Switzerland Poway, United States
Employees
6 90 larger
Industry
Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Series A Not tracked yet
Total Funding
$3.23M Not tracked yet
Funding Rounds
5 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cardiovascular Disease, Vascular Calcification, Diagnostic Devices, T50 Test, Chronic Kidney Disease, Medical Diagnostics, Biomineralization, Preventive Medicine, Individualized Care, Swiss Healthcare, Health Technology, Medical Prognosis, Medical Devices, Precision Medicine Clinical Diagnostics, Enzyme Technologies, Diagnostic Reagents, Cardiovascular Disease, Liver Disease, Cancer Markers, Renal Disease, Electrolytes, Medical Device Manufacturer, CGMP Certified, ISO 13485 Certified, Poway, California
Website
calciscon.com diazyme.com
Calciscon AG logo

About Calciscon AG

**Calciscon** is a Switzerland-based health care startup founded in 2013, specializing in the development and marketing of diagnostic devices for the assessment of calcification-related cardiovascular (CV) disease. The company's slogan, "**Calcification Propensity Diagnostics can predict effective d...

Diazyme Laboratories, Inc. logo

About Diazyme Laboratories, Inc.

Diazyme Laboratories, Inc. is a biotechnology and healthcare company founded in 2000 with the slogan "Innovations in Clinical Diagnostics." The company is based in United States and is dedicated to developing diagnostic reagents using proprietary enzyme technologies. These reagents can be convenient...

We will tell you when either one moves

BounceWatch watches Calciscon AG and Diazyme Laboratories, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Calciscon AG and Diazyme Laboratories,... — by email.

Frequently Asked Questions

Calciscon AG — Calcification Propensity Diagnostics can predict effective drugs to slow down vascular calcification and prevent cardiovascular disease.. Diazyme Laboratories, Inc. — Innovations in Clinical Diagnostics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Calciscon AG has raised $3.23M while Diazyme Laboratories, Inc. has raised undisclosed funding.
Calciscon AG and Diazyme Laboratories, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Calciscon AG with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Calciscon AG on 11 Sep 2024, and Diazyme Laboratories, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy